Sirtuin 1 缺失加重脓毒症炎症与死亡率
该研究在 C57BL/6J 小鼠行盲肠结扎穿刺(CLP)建立脓毒症模型,比较全身 SIRT1 敲除(S1KO)、髓系细胞特异性 SIRT1 敲除(S1KO-LysMCre)与对照小鼠。CLP 后 S1KO 小鼠肾线粒体复合物 I、II 依赖呼吸能力及脂肪酸氧化速率降低,血尿素氮升高,血清 IL-6 升高;S1KO 与 S1KO-LysMCre 小鼠 5 天生存率均低于对照。作者认为 SIRT1 缺失加重脓毒症全身炎症,髓系细胞 SIRT1 活性可能是 SIRT1 保护作用的重要贡献者。
要点
- CLP 后 S1KO 小鼠肾线粒体复合物 I 依赖呼吸能力 241.7 vs 418.3 mmolO2/mg/min(p=0.018),复合物 II 依赖呼吸能力 932.3 vs 1,178.4(p=0.027)。
- CLP 后 S1KO 小鼠脂肪酸氧化速率 187.3 vs 250.3(p=0.022),血尿素氮 48.0 mg/dL vs 16.0 mg/dL(p=0.049)。
- 术后 12 小时血清 IL-6:S1KO 96.5 ng/mL vs 对照 45.6 ng/mL(p=0.028);S1KO-LysMCre 35.8 ng/mL vs 对照 24.5 ng/mL(p=0.033)。
- 5 天生存率:S1KO 33.3% vs 对照 83.3%(p=0.025);S1KO-LysMCre 60% vs 对照 100%(p=0.049)。
- 作者认为髓系细胞 SIRT1 活性可能是 SIRT1 在脓毒症中保护作用的重要贡献者。
适用人群与场景
- C57BL/6J 背景小鼠,行盲肠结扎穿刺(CLP)建立脓毒症模型,观察至术后 5 天。
研究设计与关键结果
- 研究类型为动物实验,比较全身 SIRT1 敲除(S1KO)、髓系细胞特异性 SIRT1 敲除(S1KO-LysMCre)与对照小鼠在 CLP 后的炎症、肾线粒体功能、肾损伤与生存。
- CLP 后 S1KO 小鼠肾线粒体复合物 I 依赖呼吸能力 241.7 vs 对照 418.3 mmolO2/mg/min(p=0.018),复合物 II 依赖呼吸能力 932.3 vs 对照 1,178.4(p=0.027)。
- CLP 后 S1KO 小鼠脂肪酸氧化速率 187.3 vs 对照 250.3(p=0.022)。
- CLP 后 S1KO 小鼠血尿素氮 48.0 mg/dL vs 对照 16.0 mg/dL(p=0.049)。
- 术后 12 小时血清 IL-6:S1KO 96.5 ng/mL vs 对照 45.6 ng/mL(p=0.028);S1KO-LysMCre 35.8 ng/mL vs 对照 24.5 ng/mL(p=0.033)。
- 5 天生存率:S1KO 33.3% vs 对照 83.3%(p=0.025);S1KO-LysMCre 60% vs 对照 100%(p=0.049)。
证据类型、等级与局限
- 证据类型:动物实验(小鼠 CLP 脓毒症模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文为小鼠实验,未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis is a hyperinflammatory response to infection that can lead to multiorgan failure and eventually death. Often, the onset of multiorgan failure is heralded by renal dysfunction. Sirtuin 1 (SIRT1) promotes cellular stress resilience by inhibiting inflammation and promoting mitochondrial function. We hypothesize that SIRT1 plays an important role in limiting the inflammatory responses that drive organ failure in sepsis, predominantly via expression in myeloid cells.
METHODS: We performed cecal ligation and puncture (CLP) on whole body SIRT1 knockout (S1KO) and myeloid cell-specific S1KO (S1KO-LysMCre) mice on a C57BL/6J background. Serum interleukin (IL)-6 was quantified by enzyme-linked immunosorbent assay. Renal mitochondrial complex activity was measured using Oxygraph-2k (Oroboros Instruments, Innsbruck, Austria). Blood urea nitrogen (BUN) was measured from serum. Survival was monitored for up to 5 days.
RESULTS: Following CLP, S1KO mice had decreased renal mitochondrial complex I-dependent respiratory capacity (241.7 vs. 418.3 mmolO2/mg/min, p = 0.018) and renal mitochondrial complex II-dependent respiratory capacity (932.3 vs. 1,178.4, p = 0.027), as well as reduced rates of fatty acid oxidation (187.3 vs. 250.3, p = 0.022). Sirtuin 1 knockout mice also had increased BUN (48.0 mg/dL vs. 16.0 mg/dL, p = 0.049). Interleukin-6 levels were elevated in S1KO mice (96.5 ng/mL vs. 45.6 ng/mL, p = 0.028) and S1KO-LysMCre mice (35.8 ng/mL vs. 24.5 ng/mL, p = 0.033) compared with controls 12 hours after surgery. Five-day survival in S1KO (33.3% vs. 83.3%, p = 0.025) and S1KO-LysMCre (60% vs. 100%, p = 0.049) mice was decreased compared with controls.
CONCLUSION: Sirtuin 1 deletion increases systemic inflammation in sepsis. Renal mitochondrial dysfunction, kidney injury, and mortality following CLP were all exacerbated by SIRT1 deletion. Similar effects on inflammation and survival were seen following myeloid cell-specific SIRT1 deletion, indicating that SIRT1 activity in myeloid cells may be a significant contributor for the protective effects of SIRT1 in sepsis.
参考来源
- Labiner HE, Sas KM, Baur JA, et al. Sirtuin 1 deletion increases inflammation and mortality in sepsis. J Trauma Acute Care Surg. 2022. PMID: 35857031. doi:10.1097/TA.0000000000003751
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。